New diabetes clinical trial: COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Published on: December 01, 2022 at 11:00AM
Conditions:   Diabete Type 2;   Cardiovascular Diseases
Interventions:   Drug: Aspirin;   Drug: Aspirin Placebo;   Drug: Colchicine;   Drug: Colchicine Placebo
Sponsor:   Montreal Heart Institute
Not yet recruiting
https://ift.tt/zn3FrNc

Comments